
Opinion|Videos|August 26, 2024
Advancements in MIST for BPH: Options, Guidelines, and Patient-Centered Decision-Making
Fact checked by: Dean Elterman, MD, MSc
Dean Elterman, MD, covers minimally invasive surgical therapies (MIST) for BPH, including laser therapy, prostatic urethral lift, and others, their impact on BPH management, AUA guidelines, patient selection, and the role of patient preference in choosing between MIST, medication, and surgery.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Can you please provide a high-level overview of the following available minimally invasive surgical therapies (MIST) options for benign prostate dysplasia (BPH) and how they work?
- Laser therapy
- Prostatic urethral lift procedure
- Water vapor thermal therapy
- Robotic waterjet treatment
- Photoselective vaporization of the prostate
- Any other novel therapeutic options
- How has the emergence of MIST impacted the management of patients with BPH?
- What are the current American
Urological Association guidelines/recommendations for MIST? - Which patients make good candidates for MIST options?
- When/why do you consider a MIST vs surgery (patient prognosis, patient preference, comorbidities)?
- What role does patient preference play in choosing medication vs surgery vs a MIST? Please speak to the importance of shared decision-making.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures
2
Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC
3
Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study
4
Michael Cookson, MD, discusses new strategies for treatment intensification in prostate cancer
5














